Sjögren's syndrome: A condition with features of chronic graft-versus-host disease: Does duct cell adhesion or permeability play a role in pathogenesis?

Medical Hypotheses

Volumn 62, Issue 5, 2004, Pages 825-829

  Lamey, P J ^a   Lundy, F T ^a   Al Hashimi, I ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENICITY; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL INFILTRATION; CELL MEMBRANE PERMEABILITY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; DRY EYE; ELECTRON MICROSCOPY; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMORAL IMMUNITY; INFLAMMATORY CELL; LACRIMAL GLAND; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SIALOGRAPHY; SJOEGREN SYNDROME; XEROSTOMIA;

BACTERIA (MICROORGANISMS);

EID: 1942436033     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.12.025     Document Type: Article

References (39)

1. Manthorpe R, Asmussen K, Oxholm P. Primary Sjögren's syndrome: diagnostic criteria, clinical features, disease activity. J Rheumatol 1997;24(suppl 50):8-11.
2. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
3. Ciccone E, Truini M, Grossi CE. Lymphoid complement of the human salivary glands: function and pathology. Eur J Morphol 1998;36(Suppl):252-6, Aug.
4. Nakaji M, Hayashi Y, Ninomiya T, et al. Histological grading and staging in chronic hepatitis: its practical correlation. Pathol Int 2002;52:683-90.
5. Yamamoto K. Pathogenesis of Sjögren's syndrome. Autoimmun Rev 2003;2(1):13-8.
6. Mariette X. Pathophysiology of Sjögren's syndrome. Ann Med Interne (Paris) 2003;154(3):157-68, May.
7. Evanthall BG, Waldrorf DS, Talal N. Impaired lymphocyte transformation and delayed hypersensitivity in Sjögren's syndrome. J Clin Invest 1967;46:1338-45.
8. Whaley K, Chisholm DM, Goudie RB, et al. Salivary duct autoantibody in Sjögren's syndrome: correlation with focal sialadenitis in labial mucosa. Clin Exp Immunol 1969;4:273-82.
9. Kassan SS, Akizuki M, Steinberg AD, et al. Antibody to a soluble acidic nuclear antigen in Sjögren's syndrome. Amer J Med 1977;63:238-335.
10. Gratwhol AA, Moutsopoulos HM, Chused TM, et al. Sjögren's syndrome type syndrome after allogenic bone marrow transplantation. Ann Int Med 1977;87:703-6.
11. Sale GE, Strob R, Kolb H. Histopathology of hepatic acute graft-versus-host disease in the dog: a double blind study confirms the specificity of small bile duct lesions. Transplantation 1978;26:103-6.
12. Lawley TJ, Peck GL, Moutsopoulos HM, et al. Scleroderma, Sjögren's-like syndrome and graft-versus-host disease. Ann Int Med 1977;87:707-9.
13. Ogawa Y, Kuwana M, Yamazaki K, et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003;44:1888-96.
14. Nakaji M, Hayashi Y, Ninomiya T, et al. Histological grading and staging in chronic hepatitis: its practical correlation. Pathol Int 2002;52(11):683-90.
15. Fenyk JR, Warkenden PL, Goltz RW, et al. Sclerodermaous graft-versus-host disease limited to an area of measles exanthema. Lancet 1978;i:472-3.
16. Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmun Rev 2002;1:251-60.
17. Shean MA, Tu WH, Stephen BG, et al. Virus-like structures in Sjögren's syndrome. Lancet 1970;i:568-9.
18. Ramos-Casals M, Garcia-Carrasco M, Brito Zeron MP, Cervera R, Font J. Viral etiopathogenesis of Sjögren's syndrome: role of the hepatitis C virus. Autoimmun Rev 2002;1:238-43.
19. Trejo O, Ramos-Casals M, Lopez-Guillermo A, et al. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum 2003;33:19-28.
20. Terauchi M, Koi H, Hayano C, et al. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection. J Virol 2003;77:8187-95.
21. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. Immunopathogenesis of Sjögren's syndrome. Clin Rev Allergy Immunol 2003;25:89-104.
22. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329-37.
23. Letvin NL, Walker BD. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat Med 2003;9:861-6.
24. Hirata AA. Cross reaction between streptococcal M proteins and human transplantation antigens. Science 1970;168:1095-6.
25. Nair PN, Schroeder HE. Retrograde access of antigens to the minor salivary glands in the monkey Macaca fascicularis. Arch Oral Biol 1983;28:145-52.
26. Lamey P-J, Macfarlane TW, Patton DW, Samaranayake LP, Ferguson MM. Bacteraemia consequential to sialography. Br Dent J 1985;158:218-20.
27. Lewis MAO, MacFarlane TW, Lamey P-J, Leishman RE, Howie NM. Quantitative bacteriology of the parotid salivary gland in health and Sjögren's syndrome. Microb Ecol Health Dis 1993;6:29-34.
28. Gottenberg JE, Busson M, Loiseau P, et al. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003;48(8):2240-5.
29. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968;21:656-60.
30. Takeda Y. Histopathological studies of the labial salivary glands in patients with Sjögren's syndrome. Part II: electron microscopic study. Bull Tokyo Med Dent Univ 1980;27:27-42.
31. Tishler M, Paran D, Yaron M. Allergic disorders in primary Sjögren's syndrome. Scand J Rheumatol 1998;27:166-9.
32. Hiroki A, Nakamura S, Shinohara M, et al. A comparison of glandular involvement between chronic graft-versus-host disease and Sjögren's syndrome. Int J Oral Maxillofac Surg 1996;25:298-307.
33. Nelson JL. Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases. Curr Rheumatol Rep 2001;3:222-9.
34. Moutsopoulos HM, Mann DL, Johnson AH, Chused TM. Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979;301:761-3.
35. Wilson RW, Provost TT, Bias WB, et al. Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum 1984;27:1245-53.
36. Chused TM, Kassan SS, Opelz G, Moutsopoulos HM, Terasaki PI. Sjögren's syndrome association with HLA-Dw3. N Engl J Med 1977;296:895-7.
37. Fye KH, Terasaki PI, Moutsopoulos HM, Daniels TE, Michalski JP, Talal N. Association of Sjögren's syndrome with HLA-B8. Arthritis Rheum 1976;19:883-6.
38. Reichlin M, Wasicek CA. Clinical and biologic significance of antibodies to Ro/SSA. Hum Pathol 1983;14(May):401-5.
39. Garrett JR, Gjorstrup P, Klinger AH, Parsons PA. Myoepithelial activity and the appearances of sialograms: a possible role in the formation of sialectasis. Br J Radiol 1976;49:1013-7.